Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
SWOG Cancer Research Network
Status
Recruiting
NCT ID
NCT04871542
This study examines how certain risk factors (such as age, gender, other medical conditions, and the type of immunotherapy used to treat the cancer) affect whether a patient with a malignant solid tumor will develop mild or serious side effects from the immunotherapy medications. Immunotherapy is the type of treatment that helps the body's immune system fight cancer. In the future, this information may help doctors make better decisions about cancer treatments.
Intervention
Biospecimen Collection, Questionnaire Administration
Condition
Malignant Solid Neoplasm
Investigators
Krishna S Gunturu, Site Public Contact, Sharad A. Ghamande, Apurva N. Shah, Asheesh Shipstone, Mark A. Taylor, John M. Schallenkamp, Suparna Mantha, David E. Marinier, Ahmad Hanif, Kathleen Y. Butler, Ashish Sangal, Michael A. Schwartz, Marshall P. Stagg, Elizabeth John, Charles H. Nash, Vinay K. Gudena, Oleksandra Lupak, Matthew L. Ryan, Sanah Parvez, Matthias Weiss, Richard L. Deming, Ana M. Ventura, Yeun-Hee A. Park, John A. Ellerton, Aruna C. Gowda, John K. Hill, Saqib Abbasi, Brian C. Boulmay, Michael Humeniuk, Ki Y. Chung, Tareq Al baghdadi, Deborah W. Wilbur, Shahzad Siddique, Nicholas J. DiBella, Bhoomi Mehrotra, Joseph J. Merchant, Alexander Wei, Eric D. Whitman, Matthew J. Eadens, Charles S. Kuzma, Eric Y. Chen, Bryan A. Faller, Leandro P. Moraes, Bharat Jenigiri, Natalya Greyz-Yusupov, Andrew W. Pippas, Samer S. Kasbari, Yan Zhao, Andrew J. Huang, Jonathan S. Treisman, Rajesh Bajaj, Charles W. Drescher, Daniel Almquist, Seema Harichand-Herdt, Jay W. Carlson, David M. King, Emily Schillinger, Gregory A. Masters, Abdul Hai Mansoor, Samir S. Ambrale, Sigrun Hallmeyer, Ryan T. Oleszewski, Jennifer L. Heaberlin
CT Research Area
Symptom Science